Access to anti-retroviral drugs, female (%) in Libya
Libya: Access to anti-retroviral drugs, female (%) was 52.0% in 2023. ◆ Volatile
Access to anti-retroviral drugs, female in Libya, 2000–2023
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, female in Libya is 52.0%, measured in 2023.
The figure is up 10.6% on the previous year and up 48.6% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Libya peaked at 55.0% in 2018 and was at its lowest, 3.0%, in 2000.
That places Libya 116th out of 141 countries with data for 2023, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female (%) in Libya, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 3.0% | — |
| 2001 | 3.0% | +0.0% |
| 2002 | 4.0% | +33.3% |
| 2003 | 5.0% | +25.0% |
| 2004 | 6.0% | +20.0% |
| 2005 | 9.0% | +50.0% |
| 2006 | 10.0% | +11.1% |
| 2007 | 13.0% | +30.0% |
| 2008 | 17.0% | +30.8% |
| 2009 | 22.0% | +29.4% |
| 2010 | 27.0% | +22.7% |
| 2011 | 32.0% | +18.5% |
| 2012 | 35.0% | +9.4% |
| 2013 | 35.0% | +0.0% |
| 2014 | 39.0% | +11.4% |
| 2015 | 45.0% | +15.4% |
| 2016 | 47.0% | +4.4% |
| 2017 | 49.0% | +4.3% |
| 2018 | 55.0% | +12.2% |
| 2019 | 52.0% | -5.5% |
| 2020 | 52.0% | +0.0% |
| 2021 | 50.0% | -3.8% |
| 2022 | 47.0% | -6.0% |
| 2023 | 52.0% | +10.6% |
Libya compared with similar countries
- Libya's 52.0% is below the median for upper middle income countries, which is 65.0%, 80% of the median. (39 countries reporting)
- Libya's 52.0% is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 55.0%, 95% of the median. (20 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 9.2% | 3.0% | 22.0% | 10 |
| 2010s | 41.6% | 27.0% | 55.0% | 10 |
| 2020s | 50.2% | 47.0% | 52.0% | 4 |
Countries ranked near Libya
More gender data for Libya
- Child population (UN estimates and projections) 1,888 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -1.23 % change on previous year (2030)
- Population 5,998 (2030)
- Working-age population (UN estimates and projections) 5,998 (2030)
- Population (UN estimates and projections), annual growth rate 1.82 % change on previous year (2030)
- Age population, age 00, female, interpolated 58,243 (2025)
- Age population, age 00, male, interpolated 61,596 (2025)
- Age population, age 01, female, interpolated 59,014 (2025)
- Age population, age 01, male, interpolated 62,364 (2025)
- Age population, age 02, female, interpolated 60,166 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Libya?
- Access to anti-retroviral drugs, female in Libya was 52.0% in 2023, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Libya?
- The highest recorded value was 55.0% in 2018.
- What is the lowest access to anti-retroviral drugs, female recorded in Libya?
- The lowest recorded value was 3.0% in 2000.
- How does Libya rank for access to anti-retroviral drugs, female?
- Libya ranks 116th out of 141 countries with data for 2023.
- Is access to anti-retroviral drugs, female rising or falling in Libya?
- Over the last ten years it is up 48.6%. The long-run trend across the full record is volatile.
- Where does this Libya data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.